Niagen Bioscience Inc (NAGE)

Cost of Revenue

$46.16M

TTM · Period ending: · USD

NAGE logo

NAGE Cost of Revenue

Latest reported$46.16M
NAGE TTM Cost of Revenue ($0.00 → $46.16M)
High-resolution chart · PNG

NAGE cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Niagen Bioscience Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
46,162,000
46,582,000
46,234,000
45,027,000
42,309,000
40,464,000
38,011,000
35,342,000
33,528,000
32,449,000
32,790,000
33,511,000
32,841,000
31,564,000
29,253,000
27,164,000
27,038,000
27,237,000
25,959,000
25,092,000
24,088,000
23,398,000
23,983,000
23,583,000
23,161,000
21,809,000
20,522,000
19,254,000
17,709,000
16,819,000
15,502,000
14,841,837
14,251,837
12,403,837
10,723,837
10,370,316
9,275,641
11,868,773
13,999,299
13,420,401
15,151,755
14,080,311
13,533,132
13,593,946
12,405,031
11,231,731
9,987,514
8,815,207
8,166,463
7,455,233
7,027,829
8,037,834
8,447,805
8,607,563
9,335,057
8,076,910
7,060,020
6,511,162
5,640,792
5,421,117
5,119,642
5,020,756
4,621,525
4,376,684
4,270,101
3,877,000
3,736,435
3,696,951
3,625,747
3,593,581
2,614,527
1,714,744
832,905
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.